Opening company page
Loading content and analysis data…
Loading content and analysis data…
Showing the near-term range, based on the latest 5 completed sessions and updated after each close.
Hold and monitor; no addition yet
Signals require closing-price and volume confirmation; review the company research below before acting.
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close below $75.12 → consider reducing
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close above $78.81 → consider a staged addition
The conclusion first, followed by the evidence that matters most.
Watch — await combined confirmation. An entry assessment has not yet been established.
Company events, industry developments and market conditions — facts separated from possible explanations.
US 10Y yield 5.15%2026-11-13T19:59:54.000Z
VIX 19.302026-11-13T21:15:01.000Z
Dollar index 103.412026-11-13T21:59:59.000Z
MO +0.92% · SPY -0.36% · Peer average +1.61% (CL, CLX, EL, GIS, HSY, KDP)
2026-11-13T21:00:02.000Z · Yahoo · Aligned-session reference, not a causal attribution.
Ranked by model assessment and recency. Labels use the original model impact, not expected returns. Impact percentages are model estimates, not observed price changes, probabilities or guaranteed returns.
MO is the named subject, and the article highlights its ability to preserve revenue resilience and pricing power in inflation, supporting cash flow and dividends.
Also named: PM · UVV · STZ · BF.B
MO is the article’s focal point; if pricing only partially offsets volume declines, investors will mark down the stability of its cigarette revenue and margin profile.
Also named: BTI · PM · WBA · PG
The 89.3% payout ratio is not a fresh operating catalyst, but with revenue essentially flat and margins still high, investors may read it as acceptable dividend coverage that supports MO’s income valuation.
Also named: BTI · PM · UVV
Altria's NJOY vapes and on! nicotine pouches stand to benefit from faster approvals, easing prior regulatory delays that constrained new product rollout
Also named: PM · BTI · TPB
The dividend increase continues years of expected hikes, mainly reinforcing income-investor confidence without providing new fundamental information beyond consensus.
Also named: PM · BTI
Business quality, financials, valuation and analyst disagreements.
Annual revenue $23.3B · latest quarter up 1% YoY · reported FY net income of $6.9B · short-sale volume share near its recent available-day average.
FY revenue
$23.3B
2025-12
Latest Q YoY
+1%
Gross margin
62.5%
FY net income
$6.9B
Diluted EPS
$4.12
Short-sale volume share
45.4%
2026-11-13 · Recent available-day avg 48.7% · near recent average
Short-sale volume as a share of trades covered by the FINRA file, not all market trading or outstanding short positions. Changes do not establish that short sellers are adding or covering positions.
Trend, moving averages, volume and key price levels — not the decline alone.
MA5 $77.22
MA10 $77.19
MA20 $75.99
MA60 $71.58
Last completed-session close $78.64 (+0.92%) · Volume / prior 20-session average 0.58×
Prior 20-session range $72.30–$79.87 · MA20 change over five sessions +1.39% · CMF20 -0.04
Confirmation to watch: a close above $79.87 with volume at least 1.5× the prior 20-session average. A heavy-volume break below $72.30 weakens the setup.
Completed daily candles only. Daily OHLCV cannot establish accumulation, shakeout or manipulation intent; CMF is a price/volume proxy, not actual fund flows. Thresholds are research rules, not validated success probabilities. Yahoo · 2026-11-13
Historical prices and volume. Drag to pan; scroll to zoom.
Conditions for reconsidering entry and developments that invalidate the thesis.
Complete the company and technical cross-check before defining entry and invalidation conditions.
Market View
Crowding
Risk temperature
Tail risk
Triggers
Price and volume
Insider signals
See every affected stock, second-order impact and risk factor. Try Pro free for 7 days — no credit card required.
Start my free trialNasdaq analyst consensus · currently available data
The takeaway
The average EPS surprise in the quarters shown is small. Positive and negative surprises can offset each other, so review each quarter separately.
Analyst estimates, not our forecast · not investment advice
Target-price summary $59.00–$85.00 · Consensus $74.38
Buy / hold / sell 4 / 4 / 1
Nasdaq · Retrieved 2026-11-14T20:18:39.718Z · The aggregate does not provide individual report dates or original theses. It does not establish undervaluation; no analyst rationale is inferred. Targets are not guaranteed outcomes.
Next-quarter EPS estimate (Dec 2026) $1.40 · $1.36–$1.49 · 6 analysts
Four-week estimate revisions: up / down 1 / 1
Estimate dispersion 9.3%
Nasdaq EPS forecasts · retrieved 2026-11-14T20:18:39.582Z